Iodide

Iodide

SCHEMBL11567337

[Cu+].[I-].c1ccc(P(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.86

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE known ✓ P22303 1/20 0.32
TDP1 Q9NUW8 3/20 0.86
CYP3A4 P08684 1/20 0.86
ESR1 P03372 4/20 0.60
ESR2 Q92731 4/20 0.60
KDM4E B2RXH2 1/20 0.46
GAA P10253 1/20 0.46
NPSR1 Q6W5P4 1/20 0.35
ALDH1A1 P00352 3/20 0.35
DRD1 P21728 2/20 0.34
APOBEC3A P31941 1/20 0.32
APOBEC3G Q9HC16 1/20 0.32
TSHR P16473 4/20 0.32
CA1 P00915 2/20 0.32
CA2 P00918 2/20 0.32
CA9 Q16790 2/20 0.32
LMNA P02545 2/20 0.32
CA12 O43570 1/20 0.32
GLA P06280 1/20 0.32
CA3 P07451 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL15521810 1.00 TDP1 (0.86) TDP1CYP3A4ESR1ESR2KDM4E
Iodide SCHEMBL7487637 0.97 TDP1 (0.80) TDP1CYP3A4ESR1ESR2KDM4E
SCHEMBL29692997 0.96 TDP1 (0.92) TDP1CYP3A4ESR1ESR2KDM4E
SCHEMBL29556770 0.96 TDP1 (0.92) TDP1CYP3A4ESR1ESR2KDM4E
Iodide SCHEMBL11614727 0.93 TDP1 (0.86) TDP1CYP3A4ESR1ESR2KDM4E
SCHEMBL1437177 0.93 TDP1 (0.86) TDP1CYP3A4ESR1ESR2KDM4E
Iodide SCHEMBL7778537 0.93 TDP1 (0.86) TDP1CYP3A4ESR1ESR2KDM4E
Iodide SCHEMBL15193635 0.93 TDP1 (0.86) TDP1CYP3A4ESR1ESR2KDM4E
Iodide SCHEMBL11614732 0.93 TDP1 (0.86) TDP1CYP3A4ESR1ESR2KDM4E
Bromide SCHEMBL621886 0.93 TDP1 (0.86) TDP1CYP3A4ESR1ESR2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103464125-B Preparation method and application of novel triazole bridging compound cyclodextrin chiral stationary phase UNIV TIANJIN 2014-12-24 CN claimed
CN-103464125-A Preparation method and application of novel triazole bridging compound cyclodextrin chiral stationary phase UNIV TIANJIN 2013-12-25 CN claimed
EP-4314144-B1 POLYAMIDE COMPOSITIONS ENVALIOR DEUTSCHLAND GMBH (DE) 2026-04-08 EP disclosed
EP-4314139-B1 POLYAMIDE COMPOSITIONS ENVALIOR DEUTSCHLAND GMBH (DE) 2026-04-08 EP disclosed
EP-3868817-B1 HIGH VOLUME COMPONENTS ENVALIOR DEUTSCHLAND GMBH (DE) 2026-03-25 EP disclosed
EP-4441132-B1 POLYAMIDE-BASED PRODUCTS ENVALIOR DEUTSCHLAND GMBH (DE) 2026-01-14 EP disclosed
US-12516177-B2 High voltage components ENVALIOR DEUTSCHLAND GMBH (DE) 2026-01-06 US disclosed
US-20250382441-A1 HIGH VOLTAGE COMPONENTS ENVALIOR DEUTSCHLAND GMBH (DE) 2025-12-18 US disclosed
US-12448497-B2 High voltage components ENVALIOR DEUTSCHLAND GMBH (DE) 2025-10-21 US disclosed
US-12398258-B2 Polyamide-based products ENVALIOR DEUTSCHLAND GMBH (DE) 2025-08-26 US disclosed
EP-3868818-B1 HIGH VOLUME COMPONENTS ENVALIOR DEUTSCHLAND GMBH (DE) 2025-02-19 EP disclosed
WO-2021047937-A1 HIGH-VOLTAGE COMPONENTS LANXESS DEUTSCHLAND GMBH (DE) 2021-03-18 WO disclosed
EP-3792303-A1 HIGH VOLTAGE COMPONENTS LANXESS Deutschland GmbH (DE) 2021-03-17 EP disclosed
EP-3792302-A1 HIGH VOLTAGE COMPONENTS LANXESS Deutschland GmbH (DE) 2021-03-17 EP disclosed
WO-2020187704-A1 HIGH VOLTAGE COMPONENTS LANXESS DEUTSCHLAND GMBH (DE) 2020-09-24 WO disclosed
WO-2020187702-A1 HIGH VOLTAGE COMPONENTS LANXESS DEUTSCHLAND GMBH (DE) 2020-09-24 WO disclosed
CN-109666294-A 56 composition of polyamide and its application that a kind of crystalline rate is promoted 会通新材料(上海)有限公司 2019-04-23 CN disclosed
CN-103464125-B Preparation method and application of novel triazole bridging compound cyclodextrin chiral stationary phase UNIV TIANJIN 2014-12-24 CN disclosed
CN-103464125-A Preparation method and application of novel triazole bridging compound cyclodextrin chiral stationary phase UNIV TIANJIN 2013-12-25 CN disclosed
US-4168271-A Unsaturated vitamin E intermediates--dehydro and didehydro α-tocopherols SCM CORPORATION (US) 1979-09-18 US disclosed